Religare Capital Markets

Jun 22, 2015 at 10:21 | Source: CNBC-TV18
In an interview with CNBC-TV18, Deepak Shenoy of Capital Mind discussed his stock and sector strategies, including recommendations from the midcap space.
Jun 21, 2015 at 14:05 | Source: PTI
With both and retail institutional demand struggling to grow, the fiscal is likely to be a "tough year" for the north Indian cement market, which accounted for 31 percent of the country's consumption in 2014-15, a report said.
Jun 20, 2015 at 13:26 | Source: CNBC-TV18
Purav Jhaveri of Franklin Templeton expects the economy to improve with correction in the market and better earnings in future.
Jun 19, 2015 at 16:45 | Source: CNBC-TV18
V B Industries market capital stands at Rs 340 crore today. Its stock has gained five times since May 2015. The company invests in shares and securities and provides short term loans to corporates and high net worth individuals (HNIs).
Jun 18, 2015 at 19:42 | Source: CNBC-TV18
Lamenting that the whatever economic reforms the government has done have been incremental rather than 'big-bang', noted Morgan Stanley analyst Ruchir Sharma said the Narendra Modi government should have been quicker in its first year of government when it had more political capital.
Jun 18, 2015 at 16:19 | Source: CNBC-TV18
Vineet Bhatnagar, Managing Director of PhillipCapital spoke to CNBC-TV18's Latha Venkatesh and Nigel D'Souza from the sidelines of the firm's conference '365 Days of Modi Government', and discussed the recent market selloff and the outlook forward.
Jun 18, 2015 at 09:32 | Source: CNBC-TV18
Watch the interview of Manoj Murlidharan of Religare Securities with Sonia Shenoy & Latha Venkatesh on CNBC-TV18, in which he shared his readings and outlook on Futures and Options (F&O) side of the market, specific stocks and sectors.
Jun 17, 2015 at 17:56 | Source: PTI
The IPO subscription would close on June 26. Gujarat-based Manpasand, which will be the eighth company to launch an IPO this year, has fixed a price band of Rs 290-320 per piece for the issue.
Jun 17, 2015 at 17:31 | Source: PTI
"Based on the recommendations of Foreign Investment Promotion Board (FIPB)... Government has approved 16 proposals of Foreign Direct Investment (FDI) amounting to Rs 6,750.86 crore," Finance Ministry said in a statement.
Jun 17, 2015 at 15:19 | Source: CNBC-TV18
While maintaining that incrementally there have been a few macro positive in terms of coal dispatches and industrial output over the past few days, Naveen Kulkarni, Co-Head Research, PhillipCapital says he expects corporate earnings to revive meaningfully only during the second half of the year.
Messages on Religare Capital Markets »

Web Messenger

Platinum Member

293833 Followers

Indian indices  

Source:NDTV Profit - 2:30 p.m. Tirthankar Patnaik of Religare Capital Markets says that Nifty has could run up by another 100-150 points before the fundamentals catch up. (Track stocks). All the sectoral indices, except the pharma, are trading higher. Gail India, Tech

4.55 PM Mar 6th 2014

cleverman

Platinum Member

92 Followers

Ranbaxy Labs  

also the stock will have a downside of around 10-15 per cent from these levels. We recommend a sell on the stock," adds Nangra. Arvind Bothra, Vice President, institutional research, Religare Capital Markets, says, "we expect significant negative impact on stock price following this news and reiterate

8.15 PM Jan 24th 2014

BSE/NSE Announcer

Platinum Member

8252 Followers

Crompton Greave  

"). This Advertisement should be read in conjunction with, and in continuation of, the Public Announcement (PA") published on July 04, 2013 and corrigenda to the PA published on July 16, 2013 and November 09,2013 to the shareholders of Crompton Greaves Limited ("Target Company")Religare Capital Markets Ltd

5.45 PM Jan 16th 2014

Web Messenger

Platinum Member

293833 Followers

Ipca Labs  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

293833 Followers

Glenmark  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

293833 Followers

News Now  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on market movement in 2014. ET Now: Last day of 2013, how does that really set stage for what your outlook is in the initial part

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

293833 Followers

Infosys  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on Infosys. ET Now: What makes you bullish on Infosys? Dr Tirthankar Patnaik: We are positive on the whole IT sector and therefore

3.25 PM Dec 31st 2013

DLF  

The central bank will hike repo rate, or the rate at which banks borrow from the central bank (Reserve Bank of India), by a total of 50 basis points (bps) till FY14-end, believes Tirthankar Patnaik, executive vice president- institutional sales, Religare Capital Markets. So it will sock to real

11.52 AM Oct 25th 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.47 PM Oct 23rd 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.46 PM Oct 23rd 2013

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.